(C) World Health Organization
This story was originally published by World Health Organization and is unaltered.
 . . . . . . . . . .



WHO Collaborating Centre for global cancer control ushers in a new chapter [1]

[]

Date: 2024-06 

The United States of America National Cancer Institute Center for Global Health (US NCI-CGH) and the World Health Organization (WHO) have renewed their collaboration to strengthen global cancer control, building on 8 years of successful collaboration and expanding their joint work to address emerging priorities.

In the new partnership agreement, US NCI, in its role as a WHO Collaborating Centre (WHOCC), will continue activities to support WHO in the development, implementation and costing of cancer control plans, especially looking into aspects of governance and accountability through policy implementation research. This collaborative work builds on US NCI as a co-convener of the International Cancer Control Partnership (ICCP). “We are excited to expand our work with NCI, in collaboration with ICCP, that brings together United Nations agencies, NCI-designated cancer centres, governments and nongovernmental organizations to help governments develop and implement evidence-based national cancer control plans,” said Dr Satish Gopal, Director of US NCI-CGH.

The US NCI WHOCC will also provide support to the WHO Global Cancer Initiatives in cervical, breast and childhood cancers to enable progress towards achieving their established targets through cancer surveillance, the utilization of health data and the effective implementation of strategies that are relevant to localized contexts. Finally, the US NCI WHOCC will focus on building a network of leading cancer epidemiologists by engaging early career scientists. In addition to advancing the careers of young professionals in global cancer research and control, this collaboration will amplify the use and dissemination of cancer data for the benefit of the scientific community and the public.

The global cancer agenda has expanded significantly since signing their first agreement in 2016. It is accelerated by three integrated WHO global cancer initiatives in cervical, childhood and breast cancer, improvement in national cancer control planning, and driven by networks of hundreds of implementing partners.

By including the needs of people affected by cancer, WHO and NCI are opening a new chapter in cancer control, focused on people-centred approaches to innovation and care. Dr Bente Mikkelsen, Director, Department of Noncommunicable Diseases, Rehabilitation and Disability (NCD), WHO.

Throughout its years of activity, US NCI has supported more than 20 governments to strengthen their national cancer control programmes through collaboration and partnership engagement, using evidence-based, data-driven approaches to cancer planning and implementation. WHO and US NCI has also directly provided support to governments to fund their cancer plans and prepare operational plans based on health system readiness.

Collaborative activities are increasingly founded on the experience of people affected by cancer by improving research around the short- and long-term needs of cancer survivors.

WHO and the Pan American Health Organization designate US NCI-CGH among their more than 800 collaborating centres in more than 80 countries. Visit US NCI WHO Collaborating Centre for Global Cancer Control for more information.

[END]
---
[1] Url: https://www.who.int/news/item/24-06-2024-who-collaborating-centre-for-global-cancer-control-ushers-in-a-new-chapter

Published and (C) by World Health Organization
Content appears here under this condition or license: Creative Commons CC-BY-NC-SA 3.0 IGO.

via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/who/